Edgewise Therapeutics, Inc. (EWTX) Misses Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts EWTX Hot Sheet
Join SI Premium – FREE
Edgewise Therapeutics, Inc. (NASDAQ: EWTX) reported Q2 EPS of ($0.53), $0.06 worse than the analyst estimate of ($0.47).
For earnings history and earnings-related data on Edgewise Therapeutics, Inc. (EWTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. and Denmark close in on a Greenland deal - Reuters
- Ximen Mining launches $350,000 bridge placement for Kenville mine
- Trump says U.S. and Denmark reached permanent security deal over Greenland
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
